Bethune D W, Collis J M
Thorax. 1967 May;22(3):221-5. doi: 10.1136/thx.22.3.221.
Six commercially available devices were tested to determine the alveolar oxygen concentration that is achieved and the volume of rebreathing that can occur in conditions simulating clinical use. All were tested at zero oxygen flow, since failure and interruption of the oxygen supply to such devices can occur in clinical use. In patients whose cardiorespiratory reserve is exhausted, any increase in dead space will be detrimental; for such patients devices should be selected which cannot cause rebreathing under any circumstances. Three of the devices tested could cause appreciable rebreathing, Oxyaire (B.L.B. pattern), Pneumask, and the M.C. mask. Claims made for the Pneumask and the M.C. mask were not substantiated in this study. With administration by nasal catheter changes in alveolar oxygen concentrations were found to be dependent on the percentage of mouth breathing by the subject. The Ventimask produced a consistent elevation of the alveolar oxygen percentage and did not cause any increase in the dead space.
测试了六种市售设备,以确定在模拟临床使用的条件下所能达到的肺泡氧浓度以及可能发生的重复呼吸量。所有设备均在零氧流量下进行测试,因为在临床使用中此类设备可能会出现氧气供应故障和中断。对于心肺储备耗尽的患者,任何死腔增加都是有害的;对于这类患者,应选择在任何情况下都不会导致重复呼吸的设备。所测试的三种设备可能会导致明显的重复呼吸,即Oxyaire(B.L.B.模式)、Pneumask和M.C.面罩。本研究未证实Pneumask和M.C.面罩所宣称的效果。通过鼻导管给药时,发现肺泡氧浓度的变化取决于受试者口呼吸的百分比。Ventimask能持续提高肺泡氧百分比,且不会导致死腔增加。